Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164395 (US9669029, 98 8-Methoxy-5-methyl-2-{2-[1-(2-morpho...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.330 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164399 (US9669029, 102 5,8-Dimethyl-2-[2-(1-methyl-4-thiop...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.390 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164544 (US9669029, 115 5,8-Dimethyl-2-[2-(1-methyl-4-thiaz...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.400 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164545 (US9669029, 116 5,8-Dimethyl-2-[2-(1-methyl-4-pyrim...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.440 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164549 (US9669029, 117 5,8-Dimethyl-2-[2-(1-methyl-4-pyraz...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.520 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164283 (US9669029, 33 5-Methyl-2-[2-(4-thiophen-2-yl-1H-im...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.540 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164560 (US9669029, 118 5,8-Dimethyl-2-[2-(1-methyl-4-pyrid...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.550 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164284 (US9669029, 34 8-Methyl-2-[2-(4-thiophen-2-yl-1H-im...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.990 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164391 (US9669029, 94 5,8-Dimethyl-2-[2-(1-methyl-4-thioph...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164354 (US9669029, 62 8-Methoxy-5-methyl-2-[2-(1-methyl-4-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164392 (US9669029, 95 8-Methoxy-5-methyl-2-[2-(1-propyl-4-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164543 (US9669029, 114 5,8-Dimethyl-2-[2-(1-methyl-4-thiaz...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.29 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164354 (US9669029, 62 8-Methoxy-5-methyl-2-[2-(1-methyl-4-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164394 (US9669029, 97 4-{2-[2-(8-Methoxy-5-methyl-[1,2,4]t...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164396 (US9669029, 99 8-Methoxy-5-methyl-2-[2-(1-methyl-4-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164495 (US9669029, 103 5,8-Dimethyl-2-[2-(1-methyl-4-thiaz...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.30 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164501 (US9669029, 104 5,8-Dimethyl-2-[2-(1-methyl-4-thiaz...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.70 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164316 (US9669029, 50 8-Methoxy-5-methyl-2-[(E)-2-(1-methy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.70 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164350 (US9669029, 59 (R)-1-Chloro-3-{2-[2-(5-methyl-[1,2,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164536 (US9669029, 111 2-[2-(4-Furan-3-yl-1-methyl-1H-imid...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.90 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164511 (US9669029, 105 8-Methoxy-5-methyl-2-{2-[1-methyl-4...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.10 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM173102 (US9096589, 5,7-Dimethyl-2-[2-(1-propyl-4-thiophen-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.40 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164397 (US9669029, 100 2-[2-(4-Furan-3-yl-1-methyl-1H-imid...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164393 (US9669029, 96 8-Methoxy-5-methyl-2-[2-(1-prop-2-yn...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.10 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164534 (US9669029, 109 5,8-Dimethyl-2-{2-[1-methyl-4-(5-me...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.20 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164317 (US9669029, 51 5,7-Dimethyl-2-[2-(1-methyl-4-thioph...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.20 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164328 (US9669029, 52 8-Methoxy-2-[2-(1-methyl-4-thiophen-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.5 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164290 (US9669029, 40 5-Methyl-2-[2-(4-thiophen-3-yl-1H-im...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.70 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164282 (US9669029, 32 1-(4-Chloro-phenyl)-2-{2-[2-(5,7-dim...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.70 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164532 (US9669029, 107 5,8-Dimethyl-2-[2-(1-methyl-4-pyrid...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.70 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164285 (US9669029, 35 (S)-2-{2-[2-(5-Methyl-[1,2,4]triazol...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.40 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164398 (US9669029, 101 5,8-Dimethyl-2-{2-[1-methyl-4-(5-me...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.80 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM173105 (US9096589, 5,7-Dimethyl-2-{2-[1-(3-methyl-butyl)-4...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.80 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164539 (US9669029, 113 5,8-Dimethyl-2-[2-(1-methyl-4-thiaz...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.90 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164286 (US9669029, 36 1-Methoxy-3-{2-[2-(5-methyl-[1,2,4]t...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.5 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM173096 (US9096589, 5,7-Dimethyl-2-[2-(4-thiophen-2-yl-1H-i...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.60 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164272 (US9669029, 22 1-{2-[2-(5,7-Dimethyl-imidazo[1,2-a]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.90 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164380 (US9669029, 83 1-Methoxy-3-{2-[2-(8-methyl-[1,2,4]t...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.40 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164372 (US9669029, 75 [((S)-2-Hydroxy-3-{2-[2-(5-methyl-[1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.80 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM173083 (US9096589, 5,7-Dimethyl-2-[(E)-2-(1-methyl-4-thiop...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.80 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM173100 (US9096589, (S)-2-{2-[2-(5,7-Dimethyl-imidazo[1,2-a...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.80 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164533 (US9669029, 108 5,8-Dimethyl-2-[2-(1-methyl-4-pyrid...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.90 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164381 (US9669029, 84 5-Methyl-2-[2-(1-methyl-4-thiophen-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.20 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164388 (US9669029, 91 8-Methoxy-5-methyl-2-[2-(1-methyl-4-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.20 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164266 (US9669029, 16 5,7-Dimethyl-2-{2-[4-thiophen-2-yl-1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.60 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164291 (US9669029, 41 5-Methyl-2-[2-(4-pyridin-3-yl-1H-imi...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.60 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164291 (US9669029, 41 5-Methyl-2-[2-(4-pyridin-3-yl-1H-imi...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.60 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164531 (US9669029, 106 5,8-Dimethyl-2-[2-(1-methyl-4-thiaz...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164277 (US9669029, 27 2-[2-(1-Isobutyl-4-thiophen-2-yl-1H-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM173108 (US9096589, 1-{2-[2-(5,7-Dimethyl-imidazo[1,2-a]pyr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 114 total ) | Next | Last >> |